Top Qs
Timeline
Chat
Perspective
DB-OTO
Experimental gene therapy for a form of hearing loss From Wikipedia, the free encyclopedia
Remove ads
DB-OTO is an experimental gene therapy for otoferlin-related hearing loss developed by Regeneron Pharmaceuticals. It is delivered via adeno-associated virus.[1][2][3][4][5][6]
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads